---
title: Alzheimer Disease as a Clinical-Biological Construct-An International Working
  Group Recommendation
date: '2024-11-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39483064/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241102200737&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS AND RELEVANCE: The ultimate aim of the field was to foster
  effective AD treatments, including preventing symptoms and dementia. The approach
  of diagnosing AD without a clinical and biological construct would be unwarranted
  and potentially concerning without a clear knowledge of when or whether symptoms
  will ever develop. It is recommended that those who are amyloid-positive only and,
  more generally, most biomarker-positive cognitively normal individuals, should not
  be labeled ...'
disable_comments: true
---
CONCLUSIONS AND RELEVANCE: The ultimate aim of the field was to foster effective AD treatments, including preventing symptoms and dementia. The approach of diagnosing AD without a clinical and biological construct would be unwarranted and potentially concerning without a clear knowledge of when or whether symptoms will ever develop. It is recommended that those who are amyloid-positive only and, more generally, most biomarker-positive cognitively normal individuals, should not be labeled ...